StockData
Guardian Pharmacy Services, Inc. logo

Guardian Pharmacy Services, Inc. (GRDN) shareholders

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30157% above fair value
$50.33+0.90 (+1.82%)

Close on Nov 17, 2026Market cap $3.19BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
46.6%
30M of 63M shares
Institutional holders
189
36 new, 15 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 10 sales
Net sold $419.12M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Thomas J. Salentine, Jr.
Joint filing with Bindley Capital Partners I, LLC (26.30%), William E. Bindley (26.30%) and 3 more
16,705,38026.40%13D (active) amendmentSep 27, 2026
Abigail P. Johnson
Joint filing with FMR LLC (5.00%)
3,138,4595.00%13G (passive) amendmentSep 30, 2026
FMR LLC
Joint filing with Abigail P. Johnson (6.50%)
2,359,3576.50%13G (passive)Mar 31, 2026
J. Goldman Capital Management, Inc.
Joint filing with J. Goldman & Co LP (8.20%), Goldman Jay G (8.20%)
751,0848.20%13G (passive)Sep 30, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GRDNValueChange% of portfolio
FMR LLC3,241,6125.12%$135.73M+882,2550.01%
Wellington Management Group Llp1,729,0322.73%$72.39M−36,0870.01%
BlackRock, Inc.1,575,9892.49%$65.99M−180,3850.00%
Vanguard Capital Management LLC1,379,7502.18%$57.77M+154,2070.00%
Woodline Partners LP1,306,3402.06%$54.70M+220.17%
Valiant Capital Management, L.P.1,186,6581.87%$49.69M–2.01%
T. Rowe Price Investment Management, Inc.1,116,8681.76%$46.76M+88,4790.03%
Boston Partners983,8681.55%$40.80M−33,8150.04%
Franklin Resources Inc966,2061.53%$40.46M+13,2540.01%
TimesSquare Capital Management, LLC951,6371.50%$39.85M−125,837586.04%
Loomis Sayles & Co L P869,8361.37%$36.42M−61,8530.05%
Boone Capital Management LLC711,9391.12%$29.81M+80,7466.97%
Geode Capital Management, LLC646,6951.02%$27.08M+87,6600.00%
Jennison Associates LLC626,6640.99%$26.24M−196,1200.02%
State Street Corp590,1140.93%$24.71M+81,0960.00%
Bessemer Group Inc548,0290.87%$22.95M+469,3730.03%
Brown Advisory Inc524,0130.83%$21.94M−735,1610.03%
Dimensional Fund Advisors LP516,0940.81%$21.61M+307,5000.00%
Driehaus Capital Management LLC510,1610.81%$21.36M−78,9600.12%
First Trust Advisors LP461,3070.73%$19.31M+367,6300.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202618930M46.6%36 / 7453 / 155M4M
Q1 202617128M44.7%59 / 5242 / 1412M2M
Q4 202512920M31.5%33 / 5332 / 163M3M
Q3 202511220M31.1%23 / 5623 / 165M4M
Q2 202510518M28.7%36 / 4614 / 39M1M
Q1 20257410M16.3%14 / 2622 / 62M1M
Q4 20246810M15.1%35 / 1515 / 184M3M
Q3 2024518M13.3%51 / 00 / 08M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

216 funds held GRDN in Q2 2026, 27% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of GRDNValue% of fundAs of
Vanguard Total Stock Market Index Fund1,028,3131.62%$43.06M0.00%Jun 30, 2026
Fidelity Stock Selector Small Cap Fund538,3250.85%$21.28M0.29%Jul 31, 2026
Putnam Core Equity Fund508,1350.80%$20.09M0.32%Jul 31, 2026
Fidelity Small Cap Growth Fund476,8000.75%$18.85M0.21%Jul 31, 2026
iShares Russell 2000 ETF472,7870.75%$19.80M0.02%Jun 30, 2026
Loomis Sayles Small Cap Growth Fund470,7060.74%$19.71M0.87%Jun 30, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.341,1140.54%$14.28M0.15%Jun 30, 2026
Vanguard Extended Market Index Fund319,6150.50%$13.38M0.01%Jun 30, 2026
Fidelity Series Small Cap Opportunities Fund309,0440.49%$12.22M0.26%Jul 31, 2026
AST Small-Cap Equity Portfolio288,5170.46%$12.08M0.57%Jun 30, 2026
Brown Advisory Small-Cap Fundamental Value Fund280,3470.44%$11.74M0.95%Jun 30, 2026
Templeton Global Smaller Companies Fund272,2400.43%$10.55M1.30%May 31, 2026
Fidelity Small Cap Stock Fund248,7000.39%$9.83M0.73%Jul 31, 2026
Fidelity Small Cap Growth K6 Fund241,7110.38%$9.55M0.21%Jul 31, 2026
Boston Partners Small Cap Value Fund II211,2600.33%$8.18M1.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David K. MorrisSee Remarks, Director896,3411.42%Sep 28, 2026
Fred BurkeSee Remarks, Director3,438,0645.43%Sep 28, 2026
Douglas TownsSee Remarks113,0060.18%Sep 28, 2026
Richard EakinsSenior Vice President, Sales134,9300.21%Sep 28, 2026
Jeffrey TuchSee Remarks231,8470.37%Sep 28, 2026
Robert WeirSee Remarks103,3330.16%Sep 28, 2026
David Norman MartinSee Remarks140,9050.22%Sep 28, 2026
Chris CrisafulliSee Remarks53,0570.08%Sep 28, 2026
William Franklin MuddSee Remarks136,7470.22%Sep 28, 2026
Thomas J. Salentine JrDirector, 10% owner16,705,38026.37%Sep 28, 2026
John AckermanDirector5,151,0438.13%Sep 28, 2026
William E. BindleyDirector, 10% owner16,669,66626.32%Sep 28, 2026
Mary Sue PatchettDirector15,0710.02%May 7, 2026
Steven D. CoslerDirector29,0120.05%May 7, 2026
Randall J. LewisDirector15,0710.02%May 7, 2026
Cardinal Equity Fund, L.P.–1,287,2372.03%Sep 28, 2026
Pharmacy Investors, LLC–3,863,8066.10%Sep 28, 2026
Bindley Capital Partners I, LLC10% owner16,669,66626.32%Sep 28, 2026
Kendall Forbes–1,651,0592.61%Sep 28, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
William E. Bindley
Director, 10% owner
Sep 27, 2026Option exercise+6,100,175––16,669,666
Fred Burke
See Remarks, Director
Sep 27, 2026Option exercise+1,298,825––3,438,064
David K. Morris
See Remarks, Director
Sep 27, 2026Option exercise+641,870––896,341
Thomas J. Salentine Jr
Director, 10% owner
Sep 27, 2026Option exercise+6,100,175––16,669,666
William Franklin Mudd
See Remarks
Sep 27, 2026Option exercise+38,282––136,747
Bindley Capital Partners I, LLC
10% owner
Sep 27, 2026Option exercise+6,100,175––16,669,666
Chris Crisafulli
See Remarks
Sep 27, 2026Option exercise+18,931––53,057
David Norman Martin
See Remarks
Sep 27, 2026Option exercise+39,865––140,905
Robert Weir
See Remarks
Sep 27, 2026Option exercise+23,450––103,333
Pharmacy Investors, LLC
–
Sep 27, 2026Option exercise+1,413,939––3,863,806
John Ackerman
Director
Sep 27, 2026Option exercise+1,413,939––3,863,806
John Ackerman
Director
Sep 27, 2026Option exercise+471,057––1,287,237
Douglas Towns
See Remarks
Sep 27, 2026Option exercise+23,450––113,006
Cardinal Equity Fund, L.P.
–
Sep 27, 2026Option exercise+471,057––1,287,237
Jeffrey Tuch
See Remarks
Sep 27, 2026Option exercise+55,578––231,847
Kendall Forbes
–
Sep 27, 2026Option exercise+608,570––1,651,059
Richard Eakins
Senior Vice President, Sales
Sep 27, 2026Option exercise+36,052––134,930
Randall J. Lewis
Director
May 5, 2026Award+4,028––15,071
Mary Sue Patchett
Director
May 5, 2026Award+4,028––15,071
Steven D. Cosler
Director
May 5, 2026Award+4,028––29,012
Fred Burke
See Remarks, Director
Mar 28, 2026Option exercise+1,298,826––2,139,239
Pharmacy Investors, LLC
–
Mar 28, 2026Option exercise+1,413,939––2,449,867
Cardinal Equity Fund, L.P.
–
Mar 28, 2026Option exercise+471,057––816,180
Kendall Forbes
See Remarks
Mar 28, 2026Option exercise+608,570––1,061,826
William E. Bindley
Director, 10% owner
Mar 28, 2026Option exercise+6,100,175––10,569,491
Bindley Capital Partners I, LLC
10% owner
Mar 28, 2026Option exercise+6,100,175––10,569,491
David K. Morris
See Remarks, Director
Mar 28, 2026Option exercise+641,869––896,341
Thomas J. Salentine Jr
Director, 10% owner
Mar 28, 2026Option exercise+6,100,175––10,569,491
John Ackerman
Director
Mar 28, 2026Option exercise+471,057––816,180
John Ackerman
Director
Mar 28, 2026Option exercise+1,413,939––2,449,867
Cardinal Equity Fund, L.P.
–
Mar 20, 2026Sale−275,728$29.68$8.18M345,123
Pharmacy Investors, LLC
–
Mar 20, 2026Sale−827,636$29.68$24.56M1,035,928
Fred Burke
See Remarks, Director
Mar 20, 2026Sale−671,432$29.68$19.93M840,413
David K. Morris
See Remarks, Director
Mar 20, 2026Sale−187,855$29.68$5.58M254,472
John Ackerman
Director
Mar 20, 2026Sale−827,636$29.68$24.56M1,035,928
John Ackerman
Director
Mar 20, 2026Sale−275,728$29.68$8.18M345,123
Kendall Forbes
See Remarks
Mar 20, 2026Sale−346,672$29.68$10.29M453,256
Thomas J. Salentine Jr
Director, 10% owner
Mar 20, 2026Sale−3,570,677$29.68$105.98M4,469,316
Bindley Capital Partners I, LLC
10% owner
Mar 20, 2026Sale−3,570,677$29.68$105.98M4,469,316
William E. Bindley
Director, 10% owner
Mar 20, 2026Sale−3,570,677$29.68$105.98M4,469,316
Kendall Forbes
See Remarks
Mar 1, 2026Award+8,952––799,928
David K. Morris
See Remarks, Director
Mar 1, 2026Award+8,952––442,327
Fred Burke
See Remarks, Director
Dec 4, 2025Gift−200,000––1,511,845
Kendall Forbes
See Remarks
Dec 4, 2025Gift−21,500––790,976
Steven D. Cosler
Director
Dec 3, 2025Buy+3,370$29.61$99.79K24,984
Bindley Capital Partners I, LLC
10% owner
Sep 27, 2025Option exercise+6,100,176––8,039,993
Cardinal Equity Fund, L.P.
–
Sep 27, 2025Option exercise+471,057––620,851
Pharmacy Investors, LLC
–
Sep 27, 2025Option exercise+1,413,940––1,863,564
John Ackerman
Director
Sep 27, 2025Option exercise+471,057––620,851
John Ackerman
Director
Sep 27, 2025Option exercise+1,413,940––1,863,564
Kendall Forbes
See Remarks
Sep 27, 2025Option exercise+608,570––812,476
Fred Burke
See Remarks, Director
Sep 27, 2025Option exercise+1,298,826––1,711,845
Thomas J. Salentine Jr
Director, 10% owner
Sep 27, 2025Option exercise+6,100,176––8,039,993
William E. Bindley
Director, 10% owner
Sep 27, 2025Option exercise+6,100,176––8,039,993
David K. Morris
See Remarks, Director
Sep 27, 2025Option exercise+641,869––856,364
Cardinal Equity Fund, L.P.
–
May 28, 2025Sale−50,305$20.16$1.01M149,794
Pharmacy Investors, LLC
–
May 28, 2025Sale−150,998$20.16$3.04M449,624
Fred Burke
See Remarks, Director
May 28, 2025Sale−138,705$20.16$2.80M413,019
David K. Morris
See Remarks, Director
May 28, 2025Sale−68,547$20.16$1.38M214,495
Thomas J. Salentine Jr
Director, 10% owner
May 28, 2025Sale−651,454$20.16$13.13M1,939,817

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
6.17%
2M shares short
Days to cover
6.6
At 0M shares a day
Change since last report
-7.5%
From 2M shares
Short volume, 20 days
60.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Guardian Pharmacy Services's stock actually held short. Settlement fails (shares not delivered on time) peaked at 700 shares on Sep 21, 2026 over the last 90 days.

See a number that looks wrong?